Latest Ratings for KALV
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Needham | Maintains | Buy | |
| Dec 2021 | Needham | Maintains | Buy | |
| Feb 2021 | Roth Capital | Maintains | Buy |
KalVista Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
